Get App Open
In App
Lending
Lending
Open App
you are here:

Emcure Pharmaceuticals Ltd.

BSE: 544210 | NSE: EMCURE |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE168P01015 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Sep 05, 16:01
1376.80 6.90 (0.50%)
Volume
AVERAGE VOLUME
5-Day
9,643
10-Day
21,578
30-Day
18,067
3,232
  • Prev. Close

    1369.90

  • Open Price

    1371.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Sep 05, 15:58
1372.70 2.00 (0.15%)
Volume
AVERAGE VOLUME
5-Day
309,849
10-Day
278,852
30-Day
210,353
57,848
  • Prev. Close

    1370.70

  • Open Price

    1369.10

  • Bid Price (Qty.)

    1372.70 (26)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Profit & Loss account of Emcure Pharmaceuticals (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 4,334.48 3,468.98 3,088.99 3,378.93 3,127.20  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 0.00 0.00  
Revenue From Operations [Net] 4,334.48 3,468.98 3,088.99 3,378.93 3,127.20  
Total Operating Revenues 4,381.92 3,497.66 3,107.09 3,387.24 3,153.66  
Other Income 118.81 138.26 125.35 132.68 111.91  
Total Revenue 4,500.73 3,635.91 3,232.44 3,519.92 3,265.57  
EXPENSES  
Cost Of Materials Consumed 1,307.98 1,087.82 938.87 1,072.09 1,047.32  
Purchase Of Stock-In Trade 825.70 376.85 260.38 282.90 307.04  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade -126.27 -101.70 14.45 -36.10 -107.96  
Employee Benefit Expenses 782.31 706.41 649.18 603.95 550.96  
Finance Costs 112.96 166.09 166.83 145.14 123.34  
Depreciation And Amortisation Expenses 224.97 204.83 178.52 165.79 156.24  
Other Expenses 945.37 986.39 805.72 669.74 612.90  
Total Expenses 4,073.02 3,426.69 3,013.95 2,903.50 2,689.84  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 427.71 209.23 218.48 616.42 575.74  
Exceptional Items 0.00 -9.32 -6.15 0.00 -18.29  
Profit/Loss Before Tax 427.71 199.91 212.34 616.42 557.45  
Tax Expenses-Continued Operations  
Current Tax 112.71 38.58 51.05 152.62 144.29  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax -2.13 0.50 -0.83 0.89 -4.15  
Tax For Earlier Years 0.00 0.00 2.05 16.10 -3.17  
Total Tax Expenses 110.58 39.08 52.28 169.61 136.97  
Profit/Loss After Tax And Before ExtraOrdinary Items 317.13 160.83 160.06 446.81 420.48  
Profit/Loss From Continuing Operations 317.13 160.83 160.06 446.81 420.48  
Profit/Loss For The Period 317.13 160.83 160.06 446.81 420.48  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 16.95 8.89 8.85 24.71 23.25  
Diluted EPS (Rs.) 16.95 8.89 8.85 24.71 23.25  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 0.00  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 0.00  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 0.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 0.00 54.26 36.17 54.26 18.09  
Tax On Dividend 0.00 0.00 0.00 0.00 0.00  
Equity Dividend Rate (%) 30.00 30.00 20.00 10.00 10.00  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals & Drugs Sector

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970